Trastuzumab (HER2-targeted therapy)
Treatment used for 1 condition
Total Trials
89
Total Participants
75K
Avg Effectiveness
85%
Avg Safety Score
55%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.